Fresenius | FRE - Equity Capital And Reserves


Fresenius reported EUR18.62B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Akzo Nobel EUR 4.66B 728M Dec/2025
Alcon AG USD 22.03B 52M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Beiersdorf EUR 8.6B 133M Dec/2025
DaVita Healthcare Partners USD -651.08M 79.21M Dec/2025
Demant DKK 9.84B 446M Dec/2025
E.ON EUR 19.26B 5.04B Dec/2025
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Getinge SEK 33.01B 2.75B Dec/2024
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GN Store Nord DKK 14.88B 4.33B Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Philips EUR 10.58B 204M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
RWE EUR 37.67B 4.21B Sep/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025